Skip to main content
Fig. 3 | Antimicrobial Resistance & Infection Control

Fig. 3

From: Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime–avibactam: a surveillance study from the ATLAS program (2012–2016)

Fig. 3

Trends of susceptibility toceftaroline andceftazidime–avibactam against multi-drug resistant bacteria over time in different regions using the CLSI breakpoint. a Susceptibility to ceftaroline ofMRSA. b Susceptibility to ceftazidime–avibactam of CRKPN. c Susceptibility to ceftazidime–avibactam ofCRPAE. AM Africa/Middle-East, EU Europe, LA Latin America, NA North America, MRSA methicillin-resistant Staphylococcus aureus, CRKPN carbapenem-resistant Klebsiella pneumonia, CRPAE carbapenem-resistant Pseudomonas aeruginosa. Data are not presented for Oceania due to the limited number of isolates

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us